Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: VC Investment Soars In Q1, Putting Biopharma On Track For A Record Year

Apr 15 2018

• By Mandy Jackson

Finance Watch

Related Content

Startups Stand Out As 13 Biotechs Raise More Than $409m

Dec 18 2015

Deal Watch: Pfizer Begins 2018 With Two Deals, Including ALS Tie-Up With Sangamo

Jan 04 2018

Pionyr Maps Tumor Microenvironment, Plans 'Surgical' Strikes

Feb 23 2018

Celgene Seeks CAR-T Leadership, Hematology Diversification With Juno Buy

Jan 23 2018

Novo Outbid As Sanofi Agrees €3.9bn Ablynx Acquisition

Jan 29 2018

Pipeline Watch: Phase III Readouts For Talazoparib, Ampion, Avatrombopag

Dec 18 2017

VC Roundup: Magenta Raises $48.5m To Improve Stem Cell Transplants

Nov 19 2016

Finance Watch: $50m Doubles Magenta's Funding To Improve Stem Cell Transplants

May 12 2017

Intercept Makes No Changes To Ocaliva NASH Study Despite PBC Safety Issues

Sep 25 2017

BioNotebook: Offerings slow on market woes, others raise venture cash

Mar 29 2014

Immuno-Oncology 2.0 Roundtable: Emerging Players Eye Crowded Field

Mar 03 2017

Emergings In Brief, September 2013

Sep 16 2013

Mapi Pharma Ltd.

Jul 26 2013

Deal Watch: Genentech Expands Upon Arvinas PROTAC Collaboration

Nov 15 2017

Cellectis Moves First Off-The-Shelf CAR-T Into US Clinical Trials

Jul 03 2017

Roche Ramps Up Cancer Portfolio With $1.7bn Ignyta Buy

Dec 22 2017

FINANCE ROUNDUP: A New VC Fund, A $60m Collaboration Boost, And 14 Funding Rounds

Nov 19 2015

AstraZeneca Keeps R&D Focus, Spins Out Phase II Neuromyelitis Optica MAb Into New Biotech

Feb 28 2018

Deal Watch: Allogene Gets Pfizer's Off-The-Shelf CAR-T Program, $300m Series A Backing

Apr 03 2018

ITBMed Raises $67M To Induce Organ Transplant Tolerance

Apr 06 2018

Enterprise Therapeutics Raises £29M To Advance Respiratory Assets

Apr 12 2018

Sofinnova Targets Later Stage Firms With €275M Healthcare Crossover Fund

Apr 05 2018

Novartis Goes Big On Gene Therapy With $8.7bn AveXis Acquisition

Apr 09 2018

Israeli Startup Ayala Taking BMS Cancer Drug Into Phase II With $17m Financing

Apr 10 2018

Morphosys Seeks US Listing To Cement Corporate Developments

Mar 23 2018

Alzheon IPO To Fund New Phase III Trialling Of Failed Alzheimer's Drug

Mar 19 2018

Finance Watch: The Curious Case Of Proteostasis' Short Attack

Mar 22 2018

Finance Watch: Despite Bad News, IPOs And Public Offerings Keep Flowing

Mar 16 2018

BioNotebook: PhaseBio closes $40m Series C round led by AstraZeneca, plus five other VC financings

Mar 13 2015

Gilead Makes Cell Therapy The Base Of Its Oncology Platform With Kite Buy

Aug 29 2017

Finance Watch: Canaan Closes New VC Fund; CARB-X Backs More Antibiotics

Aug 02 2017

Promethera Bets Liver-Derived Stem Cells Will Offer Benefits In NASH

Dec 22 2016

Related Companies

AstraZeneca PLC

Viela Bio, Inc.

Kite Pharma, Inc.

Allogene Therapeutics Inc.

Homology Medicines, Inc.

Ayala Pharmaceuticals, Inc.

Bristol Myers Squibb Company

Constellation Pharmaceuticals, Inc.

Arvinas, Inc.

Magenta Therapeutics, Inc.

Poseida Therapeutics, Inc.

Zikani Therapeutics Inc.

GSK plc

Promethera Biosciences

HealthTell Inc.

Solid Biosciences Inc.

VYNE Therapeutics Inc.

Additional Topics

Deals Financing Business Strategies Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.